Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxine Tran

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
The Journal of Clinical Endocrinology and Metabolism|October 4, 2017
Clinical and Molecular Features of Renal and Pheochromocytoma/Paraganglioma Tumor Association Syndrome (RAPTAS): Case Series and Literature ReviewRuth T Casey, Anne Y Warren, Jose Ezequiel Martin, et al.
Nature|March 8, 2023
Fumarate induces vesicular release of mtDNA to drive innate immunityVincent Zecchini, Vincent Paupe, Irene Herranz-Montoya, et al.
European Urology Focus|July 1, 2026
A Core Outcome Set for Localized Renal Cell Cancer (L-RCC-COS)Ailbhe Lawlor, Mieke Van Hemelrijck, Charlotte Moss, et al.
Nature Communications|March 20, 2015
Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolutionMichal Kovac, Carolina Navas, Stuart Horswell, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
The Journal of Clinical Endocrinology and Metabolism|October 4, 2017
Clinical and Molecular Features of Renal and Pheochromocytoma/Paraganglioma Tumor Association Syndrome (RAPTAS): Case Series and Literature ReviewRuth T Casey, Anne Y Warren, Jose Ezequiel Martin, et al.
Nature|March 8, 2023
Fumarate induces vesicular release of mtDNA to drive innate immunityVincent Zecchini, Vincent Paupe, Irene Herranz-Montoya, et al.
European Urology Focus|July 1, 2026
A Core Outcome Set for Localized Renal Cell Cancer (L-RCC-COS)Ailbhe Lawlor, Mieke Van Hemelrijck, Charlotte Moss, et al.
Nature Communications|March 20, 2015
Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolutionMichal Kovac, Carolina Navas, Stuart Horswell, et al.
Pageof 3